Z-2274-2025 Class II Ongoing

Recalled by Nuclein LLC — Austin, TX

FDA device recall Z-2274-2025 was initiated by Nuclein LLC on Jun 25, 2025 and is designated Class II. Reason for recall: Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result) The recall status is ongoing. Affected quantity: 710 units.

Recall details

Product Type
Devices
Report Date
Aug 13, 2025
Initiation Date
Jun 25, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
710 units

Product description

DASH SARS-CoV-2 & Flu A/B Test Model/Catalog Number: SG-0006 combination COVID-19 and Flu test. Each DASH SARS-CoV-2 & Flu A/B Test is individually pouched and labeled. The tests are provided to users in quantities of 10 per kit. Used on the DASH instrument.

Reason for recall

Due to manufacturing error, assay test may result in missed diagnosis or delay of treatment. (Potential false negative result)

Distribution pattern

US distribution to: Florida, New York, Texas, and West Virginia

Code information

Lot Code: Lot: BB02 UDI: (01)00850063063036(17)260220(10)BB02 Expiration Date: 20 Feb. 2026 Lot Code: Lot: BB03 UDI: (01)00850063063036(17)260220(10)BB03 Expiration Date: 20 Feb. 2026

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2274-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2274-2025. Report a data issue: hello@regdatalab.com.